Skip to main content
PMC home page
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1986;84:799–845.

Type A behavior and central serous chorioretinopathy.

L A Yannuzzi
PMCID: PMC1298752  PMID: 3590481

Full text

PDF
799

Images in this article

834FIGURE 10
on p.834

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. R., Waldron I. Behavioral and content components of the structured interview assessment of the Type A behavior pattern in women. J Behav Med. 1983 Jun;6(2):123–134. doi: 10.1007/BF00845376. [DOI] [PubMed] [Google Scholar]
  2. Annesley W. H., Jr, Tasman W. S., Le Win D. P., Tomer T. L. Retrospective evaluation of photocoagulation for idiopathic central serous chorioretinopathy. Mod Probl Ophthalmol. 1974;12(0):234–238. [PubMed] [Google Scholar]
  3. BENNETT G. Central serous retinopathy. Br J Ophthalmol. 1955 Oct;39(10):605–618. doi: 10.1136/bjo.39.10.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BERENS C., SAYAD W. Y., GIRARD L. J. Ocular allergy; the uveal tract and retina; consideration of certain experimental and clinical concepts. Trans Am Acad Ophthalmol Otolaryngol. 1952 Mar-Apr;56(2):220–241. [PubMed] [Google Scholar]
  5. BIALASIEWICZ A. Uber therapeutische Erfolge bei Retinitis centralis serosa mit Priscol-Injektionen. Klin Monbl Augenheilkd Augenarztl Fortbild. 1957;131(4):536–537. [PubMed] [Google Scholar]
  6. BOGDONOFF M. D., ESTES E. H., Jr, TROUT D. Acute effect of psychologic stimuli upon plasma non-esterified fatty acid level. Proc Soc Exp Biol Med. 1959 Mar;100(3):503–504. doi: 10.3181/00379727-100-24676. [DOI] [PubMed] [Google Scholar]
  7. BUXEDA R. Central angiospastic retinopathy; a review of the literature and report of one case. Am J Ophthalmol. 1952 Dec;35(12):1769–1775. [PubMed] [Google Scholar]
  8. Barefoot J. C., Dahlstrom W. G., Williams R. B., Jr Hostility, CHD incidence, and total mortality: a 25-year follow-up study of 255 physicians. Psychosom Med. 1983 Mar;45(1):59–63. doi: 10.1097/00006842-198303000-00008. [DOI] [PubMed] [Google Scholar]
  9. Berrocal J. A. Current worldwide management of central serous choroidopathy. Mod Probl Ophthalmol. 1974;12(0):239–241. [PubMed] [Google Scholar]
  10. Blumenthal J. A., Williams R. B., Jr, Kong Y., Schanberg S. M., Thompson L. W. Type A behavior pattern and coronary atherosclerosis. Circulation. 1978 Oct;58(4):634–639. doi: 10.1161/01.cir.58.4.634. [DOI] [PubMed] [Google Scholar]
  11. Bortner R. W. A short rating scale as a potential measure of pattern A behavior. J Chronic Dis. 1969 Jul;22(2):87–91. doi: 10.1016/0021-9681(69)90061-7. [DOI] [PubMed] [Google Scholar]
  12. Bortner R. W., Rosenman R. H., Friedman M. Familial similarity in pattern A behavior. Fathers and sons. J Chronic Dis. 1970 Jun;23(1):39–43. doi: 10.1016/0021-9681(70)90107-4. [DOI] [PubMed] [Google Scholar]
  13. Bortner R. W., Rosenman R. H. The measurement of pattern A behavior. J Chronic Dis. 1967 Jul;20(7):525–533. doi: 10.1016/0021-9681(67)90083-5. [DOI] [PubMed] [Google Scholar]
  14. CARDON P. V., Jr, GORDON R. S., Jr Rapid increase of plasma unesterified fatty acids in man during fear. J Psychosom Res. 1959 Aug;4:5–9. doi: 10.1016/0022-3999(59)90044-3. [DOI] [PubMed] [Google Scholar]
  15. Carr R. E., Noble K. G. Central serous chorioretinopathy (central serous retinopathy). Ophthalmology. 1980 Aug;87(8):841–846. doi: 10.1016/s0161-6420(80)35172-5. [DOI] [PubMed] [Google Scholar]
  16. Case R. B., Heller S. S., Case N. B., Moss A. J. Type A behavior and survival after acute myocardial infarction. N Engl J Med. 1985 Mar 21;312(12):737–741. doi: 10.1056/NEJM198503213121201. [DOI] [PubMed] [Google Scholar]
  17. Cassel G. H., Brown G. C., Annesley W. H. Central serous chorioretinopathy: a seasonal variation? Br J Ophthalmol. 1984 Oct;68(10):724–726. doi: 10.1136/bjo.68.10.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chait A., Brunzell J. D., Johnson D. G., Benson J. W., Werner P., Palmer J. P., Albers J. J., Ensinck J. W., Bierman E. L. Reduction of plasma triglyceride concentration by acute stress in man. Metabolism. 1979 May;28(5):553–561. doi: 10.1016/0026-0495(79)90197-5. [DOI] [PubMed] [Google Scholar]
  19. Chesney M. A., Rosenman R. H. Type A behavior: Observations on the past decade. Heart Lung. 1982 Jan-Feb;11(1):12–19. [PubMed] [Google Scholar]
  20. Chumbley L. C., Frank R. N. Central serous retinopathy and pregnancy. Am J Ophthalmol. 1974 Feb;77(2):158–160. doi: 10.1016/0002-9394(74)90667-9. [DOI] [PubMed] [Google Scholar]
  21. Clouse R. E., Lustman P. J. Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med. 1983 Dec 1;309(22):1337–1342. doi: 10.1056/NEJM198312013092201. [DOI] [PubMed] [Google Scholar]
  22. DELMAN M., LEUBUSCHER K. TRANSIENT MACULAR EDEMA DUE TO GRISEOFULVIN. Am J Ophthalmol. 1963 Oct;56:658–658. doi: 10.1016/0002-9394(63)90019-9. [DOI] [PubMed] [Google Scholar]
  23. DJABRI S. E., DIALLINAS N. L'IMPORTANCE DE LA LAMBLIASE COMME FACTEUR 'ETIOLOGIQUE DANS LA CHORIOR'ETINITE CENTRALE S'EREUSE. Ophthalmologica. 1964;147:264–272. doi: 10.1159/000304600. [DOI] [PubMed] [Google Scholar]
  24. Dellaporta A. Central serous retinopathy. Trans Am Ophthalmol Soc. 1976;74:144–153. [PMC free article] [PubMed] [Google Scholar]
  25. Dimsdale J. E., Hackett T. P., Catanzano D. M., White P. J. The relationship between diverse measures for Type A personality and coronary angiographic findings. J Psychosom Res. 1979;23(5):289–293. doi: 10.1016/0022-3999(79)90033-3. [DOI] [PubMed] [Google Scholar]
  26. Dimsdale J. E., Hackett T. P. Effect of denial on cardiac health and psychological assessment. Am J Psychiatry. 1982 Nov;139(11):1477–1480. doi: 10.1176/ajp.139.11.1477. [DOI] [PubMed] [Google Scholar]
  27. Dimsdale J. E., Hackett T. P., Hutter A. M., Jr, Block P. C., Catanzano D. M., White P. J. Type A behavior and angiographic findings. J Psychosom Res. 1979;23(4):273–276. doi: 10.1016/0022-3999(79)90030-8. [DOI] [PubMed] [Google Scholar]
  28. EDWARDS T. S., PRIESTLEY B. S. CENTRAL ANGIOSPASTIC RETINOPATHY. Am J Ophthalmol. 1964 Jun;57:988–998. doi: 10.1016/0002-9394(64)91046-3. [DOI] [PubMed] [Google Scholar]
  29. ENGELMAN K., MUELLER P. S., SJOERDSMA A. ELEVATED PLASMA FREE FATTY ACID CONCENTRATIONS IN PATIENTS WITH PHEOCHROMOCYTOMA. CHANGES WITH THERAPY AND CORRELATIONS WITH THE BASAL METABOLIC RATE. N Engl J Med. 1964 Apr 23;270:865–870. doi: 10.1056/NEJM196404232701702. [DOI] [PubMed] [Google Scholar]
  30. Eastwood M. R., Trevelyan H. Stress and coronary heart disease. J Psychosom Res. 1971 Sep;15(3):289–292. doi: 10.1016/0022-3999(71)90040-7. [DOI] [PubMed] [Google Scholar]
  31. Ernest J. T. The effect of systolic hypertension on rhesus monkey eyes after ocular sympathectomy. Am J Ophthalmol. 1977 Sep;84(3):341–344. doi: 10.1016/0002-9394(77)90676-6. [DOI] [PubMed] [Google Scholar]
  32. FRIEDMAN M., ROSENMAN R. H. Association of specific overt behavior pattern with blood and cardiovascular findings; blood cholesterol level, blood clotting time, incidence of arcus senilis, and clinical coronary artery disease. J Am Med Assoc. 1959 Mar 21;169(12):1286–1296. doi: 10.1001/jama.1959.03000290012005. [DOI] [PubMed] [Google Scholar]
  33. FRIEDMAN M., ROSENMAN R. H., BYERS S. SERUM LIPIDS AND CONJUNCTIVAL CIRCULATION AFTER FAT INGESTION IN MEN EXHIBITING TYPE-A BEHAVIOR PATTERN. Circulation. 1964 Jun;29:874–886. doi: 10.1161/01.cir.29.6.874. [DOI] [PubMed] [Google Scholar]
  34. FRIEDMAN M., ST GEORGE S., BYERS S. O., ROSENMAN R. H. Excretion of catecholamines, 17-ketosteroids, 17-hydroxycorticoids and 5-hydroxyindole in men exhibiting a particular behavior pattern (A) associated with high incidence of clinical coronary artery disease. J Clin Invest. 1960 May;39:758–764. doi: 10.1172/JCI104092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Frank K. A., Heller S. S., Kornfeld D. S., Sporn A. A., Weiss M. B. Type A behavior pattern and coronary angiographic findings. JAMA. 1978 Aug 25;240(8):761–763. [PubMed] [Google Scholar]
  36. Friedman M., Byers S. O., Diamant J., Rosenman R. H. Plasma catecholamine response of coronary-prone subjects (type A) to a specific challenge. Metabolism. 1975 Feb;24(2):205–210. doi: 10.1016/0026-0495(75)90022-0. [DOI] [PubMed] [Google Scholar]
  37. Friedman M., Byers S. O., Roseman R. H., Elevitch F. R. Coronary-prone individuals (type A behavior pattern. Some biochemical characteristics. JAMA. 1970 May 11;212(6):1030–1037. [PubMed] [Google Scholar]
  38. Friedman M., Thoresen C. E., Gill J. J., Ulmer D., Thompson L., Powell L., Price V., Elek S. R., Rabin D. D., Breall W. S. Feasibility of altering type A behavior pattern after myocardial infarction. Recurrent Coronary Prevention Project Study: methods, baseline results and preliminary findings. Circulation. 1982 Jul;66(1):83–92. doi: 10.1161/01.cir.66.1.83. [DOI] [PubMed] [Google Scholar]
  39. Friedman M. Type A behavior pattern: some of its pathophysiological components. Bull N Y Acad Med. 1977 Sep;53(7):593–604. [PMC free article] [PubMed] [Google Scholar]
  40. Friedman M. Type A behavior pattern: some of its pathophysiological components. Bull N Y Acad Med. 1977 Sep;53(7):593–604. [PMC free article] [PubMed] [Google Scholar]
  41. GORDON R. S., Jr, CHERKES A. Unesterified fatty acid in human blood plasma. J Clin Invest. 1956 Feb;35(2):206–212. doi: 10.1172/JCI103265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Gass J. D. Photocoagulation of macular lesions. Trans Am Acad Ophthalmol Otolaryngol. 1971 May-Jun;75(3):580–608. [PubMed] [Google Scholar]
  43. Gass J. D. Photocoagulation treatment of idiopathic central serous choroidopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 May-Jun;83(3 Pt 1):456–467. [PubMed] [Google Scholar]
  44. Gaudric A., Coscas G., Bird A. C. Choroidal ischemia. Am J Ophthalmol. 1982 Oct;94(4):489–498. doi: 10.1016/0002-9394(82)90242-2. [DOI] [PubMed] [Google Scholar]
  45. Gilbert C. M., Owens S. L., Smith P. D., Fine S. L. Long-term follow-up of central serous chorioretinopathy. Br J Ophthalmol. 1984 Nov;68(11):815–820. doi: 10.1136/bjo.68.11.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Glass D. C., Krakoff L. R., Contrada R., Hilton W. F., Kehoe K., Mannucci E. G., Collins C., Snow B., Elting E. Effect of harassment and competition upon cardiovascular and plasma catecholamine responses in type A and type B individuals. Psychophysiology. 1980 Sep;17(5):453–463. doi: 10.1111/j.1469-8986.1980.tb00183.x. [DOI] [PubMed] [Google Scholar]
  47. HENRY M. D. Angiospastic retinopathy. Am J Ophthalmol. 1952 Oct;35(10):1509–1510. [PubMed] [Google Scholar]
  48. HOBBS H. E. Macular degeneration treated with cortisone. Proc R Soc Med. 1953 Mar;46(3):213–218. [PMC free article] [PubMed] [Google Scholar]
  49. Haft J. I. Cardiovascular injury induced by sympathetic catecholamines. Prog Cardiovasc Dis. 1974 Jul-Aug;17(1):73–86. doi: 10.1016/0033-0620(74)90039-5. [DOI] [PubMed] [Google Scholar]
  50. Hamburg D. A. Frontiers of research in neurobiology. Science. 1983 Dec 2;222(4627):969–969. doi: 10.1126/science.222.4627.969. [DOI] [PubMed] [Google Scholar]
  51. Haynes S. G., Feinleib M., Levine S., Scotch N., Kannel W. B. The relationship of psychosocial factors to coronary heart disease in the Framingham study. II. Prevalence of coronary heart disease. Am J Epidemiol. 1978 May;107(5):384–402. doi: 10.1093/oxfordjournals.aje.a112557. [DOI] [PubMed] [Google Scholar]
  52. Haynes S. G., Levine S., Scotch N., Feinleib M., Kannel W. B. The relationship of psychosocial factors to coronary heart disease in the Framingham study. I. Methods and risk factors. Am J Epidemiol. 1978 May;107(5):362–383. doi: 10.1093/oxfordjournals.aje.a112556. [DOI] [PubMed] [Google Scholar]
  53. Helsing K. J., Comstock G. W., Szklo M. Causes of death in a widowed population. Am J Epidemiol. 1982 Sep;116(3):524–532. doi: 10.1093/oxfordjournals.aje.a113436. [DOI] [PubMed] [Google Scholar]
  54. Hoffman J. W., Benson H., Arns P. A., Stainbrook G. L., Landsberg G. L., Young J. B., Gill A. Reduced sympathetic nervous system responsivity associated with the relaxation response. Science. 1982 Jan 8;215(4529):190–192. doi: 10.1126/science.7031901. [DOI] [PubMed] [Google Scholar]
  55. Holmes D. S., McGilley B. M., Houston B. K. Task-related arousal of type A and type B persons: level of challenge and response specificity. J Pers Soc Psychol. 1984 Jun;46(6):1322–1327. doi: 10.1037//0022-3514.46.6.1322. [DOI] [PubMed] [Google Scholar]
  56. Ikeda H. ["Rotator interval" lesion. Part 1: Clinical study]. Nihon Seikeigeka Gakkai Zasshi. 1986 Dec;60(12):1261–1273. [PubMed] [Google Scholar]
  57. Jenkins C. D. Behavioral risk factors in coronary artery disease. Annu Rev Med. 1978;29:543–562. doi: 10.1146/annurev.me.29.020178.002551. [DOI] [PubMed] [Google Scholar]
  58. Jenkins C. D., Rosenman R. H., Friedman M. Development of an objective psychological test for the determination of the coronary-prone behavior pattern in employed men. J Chronic Dis. 1967 Jun;20(6):371–379. doi: 10.1016/0021-9681(67)90010-0. [DOI] [PubMed] [Google Scholar]
  59. Jenkins C. D., Rosenman R. H., Zyzanski S. J. Prediction of clinical coronary heart disease by a test for the coronary-prone behavior pattern. N Engl J Med. 1974 Jun 6;290(23):1271–1275. doi: 10.1056/NEJM197406062902301. [DOI] [PubMed] [Google Scholar]
  60. Jenkins C. D., Zyzanski S. J., Rosenman R. H. Coronary-prone behavior: one pattern or several? Psychosom Med. 1978 Feb;40(1):25–43. doi: 10.1097/00006842-197802000-00005. [DOI] [PubMed] [Google Scholar]
  61. Jenkins C. D., Zyzanski S. J., Rosenman R. H. Progress toward validation of a computer-scored test for the type A coronary-prone behavior pattern. Psychosom Med. 1971 May-Jun;33(3):193–202. doi: 10.1097/00006842-197105000-00001. [DOI] [PubMed] [Google Scholar]
  62. KEENEY A. H. Central serous retinosis and its relation to other acquired impairments of central vision. J Ky State Med Assoc. 1951 Apr;49(4):148–152. [PubMed] [Google Scholar]
  63. KLIEN B. A. MACULAR DISEASES: CLINICAL MANIFESTATIONS. Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:614–622. [PubMed] [Google Scholar]
  64. KLIEN B. A. Macular lesions of vascular origin. II. Functional vascular conditions leading to damage of the macula lutea. Am J Ophthalmol. 1953 Jan;36(1):1–13. [PubMed] [Google Scholar]
  65. Keller S. E., Weiss J. M., Schleifer S. J., Miller N. E., Stein M. Stress-induced suppression of immunity in adrenalectomized rats. Science. 1983 Sep 23;221(4617):1301–1304. doi: 10.1126/science.6612346. [DOI] [PubMed] [Google Scholar]
  66. Kishi S., Tso M. O., Hayreh S. S. Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol. 1985 Aug;103(8):1189–1197. doi: 10.1001/archopht.1985.01050080101029. [DOI] [PubMed] [Google Scholar]
  67. Klein M. L., Van Buskirk E. M., Friedman E., Gragoudas E., Chandra S. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol. 1974 Apr;91(4):247–250. doi: 10.1001/archopht.1974.03900060257001. [DOI] [PubMed] [Google Scholar]
  68. Kobasa S. C., Maddi S. R., Kahn S. Hardiness and health: a prospective study. J Pers Soc Psychol. 1982 Jan;42(1):168–177. doi: 10.1037//0022-3514.42.1.168. [DOI] [PubMed] [Google Scholar]
  69. Krantz D. S., Durel L. A., Davia J. E., Shaffer R. T., Arabian J. M., Dembroski T. M., MacDougall J. M. Propranolol medication among coronary patients: relationship to type A behavior and cardiovascular response. J Human Stress. 1982 Sep;8(3):4–12. doi: 10.1080/0097840X.1982.9936109. [DOI] [PubMed] [Google Scholar]
  70. Landers M. B., 3rd, Shaw H. E., Jr, Anderson W. B., Jr, Sinyai A. J. Argon laser treatment of central serous chorioretinopathy. Ann Ophthalmol. 1977 Dec;9(12):1567–1572. [PubMed] [Google Scholar]
  71. Laties A. M., Jacobowitz D. A comparative study of the autonomic innervation of the eye in monkey, cat, and rabbit. Anat Rec. 1966 Dec;156(4):383–395. doi: 10.1002/ar.1091560403. [DOI] [PubMed] [Google Scholar]
  72. Leaver P., Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1979 Oct;63(10):674–677. doi: 10.1136/bjo.63.10.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Levy S. M., Herberman R. B., Maluish A. M., Schlien B., Lippman M. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol. 1985;4(2):99–113. doi: 10.1037//0278-6133.4.2.99. [DOI] [PubMed] [Google Scholar]
  74. Lipowski Z. J., Kiriakos R. Z. Psychosomatic aspects of central serous retinopathy. A review and case report. Psychosomatics. 1971 Nov-Dec;12(6):398–401. doi: 10.1016/S0033-3182(71)71483-2. [DOI] [PubMed] [Google Scholar]
  75. Loewenstein A. RETINOPATHIA CENTRALIS ANGIOSPASTICA (ANGIONEUROTICA), AND SEROSA ALLERGICA, AND THEIR RELATION TO DETACHMENT OF THE RETINA. Br J Ophthalmol. 1941 Aug;25(8):369–383. doi: 10.1136/bjo.25.8.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Lowder C. Y., Gutman F. A., Zegarra H., Zakov Z. N., Lowder J. N., Clough J. D. Macular and paramacular detachment of the neurosensory retina associated with systemic diseases. Trans Am Ophthalmol Soc. 1981;79:347–370. [PMC free article] [PubMed] [Google Scholar]
  77. Lyons D. E. Conservative management of central serous retinopathy. Trans Ophthalmol Soc U K. 1977 Apr;97(1):214–216. [PubMed] [Google Scholar]
  78. MAUMENEE A. E. MACULAR DISEASES: CLINICAL MANIFESTATIONS. Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:605–613. [PubMed] [Google Scholar]
  79. MCELROY W. T., Jr, SPITZER J. J. Effects of adrenergic blocking agents on plasma free fatty acid concentrations. Am J Physiol. 1961 Feb;200:318–322. doi: 10.1152/ajplegacy.1961.200.2.318. [DOI] [PubMed] [Google Scholar]
  80. MITSUI Y., SAKANASHI R. Central angiospastic retinopathy. Am J Ophthalmol. 1956 Jan;41(1):105–114. [PubMed] [Google Scholar]
  81. Malcolm A. T., Janisse M. P., Dyck D. G. Type A behavior, heart rate and pupillary response: effects of cold pressor and ego threat. J Psychosom Res. 1984;28(1):27–34. doi: 10.1016/0022-3999(84)90037-0. [DOI] [PubMed] [Google Scholar]
  82. Manuck S. B., Craft S., Gold K. J. Coronary-prone behavior pattern and cardiovascular response. Psychophysiology. 1978 Sep;15(5):403–411. doi: 10.1111/j.1469-8986.1978.tb01405.x. [DOI] [PubMed] [Google Scholar]
  83. Manuck S. B., Garland F. N. Coronary-prone behavior pattern, task incentive, and cardiovascular response. Psychophysiology. 1979 Mar;16(2):136–142. doi: 10.1111/j.1469-8986.1979.tb01458.x. [DOI] [PubMed] [Google Scholar]
  84. Marx J. L. The immune system "belongs in the body". Science. 1985 Mar 8;227(4691):1190–1192. doi: 10.1126/science.3975610. [DOI] [PubMed] [Google Scholar]
  85. Matthews K. A., Krantz D. S. Resemblances of twins and their parents in pattern A behavior. Psychosom Med. 1976 Mar-Apr;38(2):140–144. doi: 10.1097/00006842-197603000-00007. [DOI] [PubMed] [Google Scholar]
  86. Mayes B. T., Sime W. E., Ganster D. C. Convergent validity of type A behavior pattern scales and their ability to predict physiological responsiveness in a sample of female public employees. J Behav Med. 1984 Mar;7(1):83–108. doi: 10.1007/BF00845348. [DOI] [PubMed] [Google Scholar]
  87. McLEAN J. M., GORDON D. M., KOTEEN H. Clinical experiences with ACTH and cortisone in ocular diseases. Trans Am Acad Ophthalmol Otolaryngol. 1951 May-Jun;55:565–572. [PubMed] [Google Scholar]
  88. Miki T., Sunada I., Higaki T. [Studies on chorioretinitis induced in rabbits by stress (repeated administration of epinephrine)]. Nippon Ganka Gakkai Zasshi. 1972 Sep;76(9):1037–1045. [PubMed] [Google Scholar]
  89. NORTON E. W., GASS J. D., SMITH J. L., CURTIN V. T., DAVID N. J., JUSTICE J., Jr MACULAR DISEASES: DIAGNOSIS. FLUORESCEIN IN THE STUDY OF MACULAR DISEASE. Trans Am Acad Ophthalmol Otolaryngol. 1965 Jul-Aug;69:631–642. [PubMed] [Google Scholar]
  90. NORTON E. W., SMITH J. L., CURTIN V. T., JUSTICE J., Jr FLUORESCEIN FUNDUS PHOTOGRAPHY: AN AID IN THE DIFFERENTIAL DIAGNOSIS OF POSTERIOR OCULAR LESIONS. Trans Am Acad Ophthalmol Otolaryngol. 1964 Sep-Oct;68:755–765. [PubMed] [Google Scholar]
  91. Nanjiani M. Long-term follow-up of central serous retinopathy. Trans Ophthalmol Soc U K. 1977 Sep;97(4):656–661. [PubMed] [Google Scholar]
  92. Norholm I. Central serous retinitis. A follow-up study. Acta Ophthalmol (Copenh) 1969;47(4):890–899. doi: 10.1111/j.1755-3768.1969.tb03713.x. [DOI] [PubMed] [Google Scholar]
  93. Okamoto T., Tominaga K., Watanabe T., Iehara E. [Statistical observation upon retinitis centralis in 1963]. Nihon Ganka Kiyo. 1965 Feb;16(2):218–225. [PubMed] [Google Scholar]
  94. Ortega D. F., Pipal J. E. Challenge seeking and the type A coronary-prone behavior pattern. J Pers Soc Psychol. 1984 Jun;46(6):1328–1334. doi: 10.1037//0022-3514.46.6.1328. [DOI] [PubMed] [Google Scholar]
  95. Orzalesi N., Serra A. Nyove acquisizioni sulla patogenesi e la terapia della retinopatia sierosa centrale. Angiografia retinica a fluorescenza e trattamento con laser. Boll Ocul. 1969 Jul;48(7):471–490. [PubMed] [Google Scholar]
  96. PURNELL J. E., LEOPOLD I. H. Cortisone in ocular disease: further studies. Am J Ophthalmol. 1952 May;35(5 1):663–670. doi: 10.1016/0002-9394(52)90942-2. [DOI] [PubMed] [Google Scholar]
  97. Paulley J. W. Ulcers, heart disease, and type-A behaviour. Lancet. 1979 Dec 8;2(8154):1238–1238. doi: 10.1016/s0140-6736(79)92352-3. [DOI] [PubMed] [Google Scholar]
  98. Peabody R. R., Zweng H. C., Little H. L. Treatment of persistent central serous retinopathy. Arch Ophthalmol. 1968 Feb;79(2):166–169. doi: 10.1001/archopht.1968.03850040168011. [DOI] [PubMed] [Google Scholar]
  99. Pecora J. L. Ibuprofen in the treatment of central serous chorioretinopathy. Ann Ophthalmol. 1978 Nov;10(11):1481–1483. [PubMed] [Google Scholar]
  100. Pettingale K. W., Morris T., Greer S., Haybittle J. L. Mental attitudes to cancer: an additional prognostic factor. Lancet. 1985 Mar 30;1(8431):750–750. doi: 10.1016/s0140-6736(85)91283-8. [DOI] [PubMed] [Google Scholar]
  101. Psychosocial influences on mortality after myocardial infarction. N Engl J Med. 1985 Jan 3;312(1):50–51. doi: 10.1056/NEJM198501033120113. [DOI] [PubMed] [Google Scholar]
  102. Rahe R. H., Hervig L., Rosenman R. H. Heritability of type A behavior. Psychosom Med. 1978 Oct;40(6):478–486. doi: 10.1097/00006842-197810000-00003. [DOI] [PubMed] [Google Scholar]
  103. Rahe R. H., Lind E. Psychosocial factors and sudden cardiac death: a pilot study. J Psychosom Res. 1971 Mar;15(1):19–24. doi: 10.1016/0022-3999(71)90069-9. [DOI] [PubMed] [Google Scholar]
  104. Rahe R. H., Ward H. W., Hayes V. Brief group therapy in myocardial infarction rehabilitation: three- to four-year follow-up of a controlled trial. Psychosom Med. 1979 May;41(3):229–242. doi: 10.1097/00006842-197905000-00006. [DOI] [PubMed] [Google Scholar]
  105. Robertson D. M., Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983 Apr;95(4):457–466. doi: 10.1016/0002-9394(83)90265-9. [DOI] [PubMed] [Google Scholar]
  106. Rosenman R. H., Brand R. J., Jenkins D., Friedman M., Straus R., Wurm M. Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. JAMA. 1975 Aug 25;233(8):872–877. [PubMed] [Google Scholar]
  107. Rosenman R. H., Brand R. J., Sholtz R. I., Friedman M. Multivariate prediction of coronary heart disease during 8.5 year follow-up in the Western Collaborative Group Study. Am J Cardiol. 1976 May;37(6):903–910. doi: 10.1016/0002-9149(76)90117-x. [DOI] [PubMed] [Google Scholar]
  108. Rosenman R. H., Friedman M., Jenkins C. D., Straus R., Wurm M., Kositchek R. Clinically unrecognized myocardial infarction in the Western Collaborative Group Study. Am J Cardiol. 1967 Jun;19(6):776–782. doi: 10.1016/0002-9149(67)90498-5. [DOI] [PubMed] [Google Scholar]
  109. Rosenman R. H., Friedman M., Straus R., Jenkins C. D., Zyzanski S. J., Wurm M. Coronary heart disease in the Western Collaborative Group Study. A follow-up experience of 4 and one-half years. J Chronic Dis. 1970 Sep;23(3):173–190. doi: 10.1016/0021-9681(70)90094-9. [DOI] [PubMed] [Google Scholar]
  110. Ruberman W., Weinblatt E., Goldberg J. D., Chaudhary B. S. Psychosocial influences on mortality after myocardial infarction. N Engl J Med. 1984 Aug 30;311(9):552–559. doi: 10.1056/NEJM198408303110902. [DOI] [PubMed] [Google Scholar]
  111. SIE-BOEN-LIAN THE ETIOLOGICAL AGENT OF SEROUS CENTRAL CHORIORETINITIS. Ophthalmologica. 1964;148:263–270. doi: 10.1159/000304784. [DOI] [PubMed] [Google Scholar]
  112. Schatz H. Central serous chorioretinopathy and serous detachment of the retinal pigment epithelium. Int Ophthalmol Clin. 1975 Spring;15(1):159–168. doi: 10.1097/00004397-197501510-00013. [DOI] [PubMed] [Google Scholar]
  113. Schatz H., Yannuzzi L. A., Gitter K. A. Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977 Sep-Oct;83(5):893–906. [PubMed] [Google Scholar]
  114. Schmieder R., Friedrich G., Neus H., Rüdel H., von Eiff A. W. The influence of beta blockers on cardiovascular reactivity and Type A behavior pattern in hypertensives. Psychosom Med. 1983 Oct;45(5):417–423. doi: 10.1097/00006842-198310000-00005. [DOI] [PubMed] [Google Scholar]
  115. Shavit Y., Lewis J. W., Terman G. W., Gale R. P., Liebeskind J. C. Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science. 1984 Jan 13;223(4632):188–190. doi: 10.1126/science.6691146. [DOI] [PubMed] [Google Scholar]
  116. Shekelle R. B., Hulley S. B., Neaton J. D., Billings J. H., Borhani N. O., Gerace T. A., Jacobs D. R., Lasser N. L., Mittlemark M. B., Stamler J. The MRFIT behavior pattern study. II. Type A behavior and incidence of coronary heart disease. Am J Epidemiol. 1985 Oct;122(4):559–570. doi: 10.1093/oxfordjournals.aje.a114135. [DOI] [PubMed] [Google Scholar]
  117. Shekelle R. B., Raynor W. J., Jr, Ostfeld A. M., Garron D. C., Bieliauskas L. A., Liu S. C., Maliza C., Paul O. Psychological depression and 17-year risk of death from cancer. Psychosom Med. 1981 Apr;43(2):117–125. doi: 10.1097/00006842-198104000-00003. [DOI] [PubMed] [Google Scholar]
  118. Simpson M. T., Olewine D. A., Jenkins C. D., Ramsey F. H., Zyzanski S. J., Thomas G., Hames C. G. Exercise-induced catecholamines and platelet aggregation in the coronary-prone behavior pattern. Psychosom Med. 1974 Nov-Dec;36(6):476–487. doi: 10.1097/00006842-197411000-00003. [DOI] [PubMed] [Google Scholar]
  119. Spalter H. F. Photocoagulation of central serous retinopathy. A preliminary report. Arch Ophthalmol. 1968 Mar;79(3):247–253. doi: 10.1001/archopht.1968.03850040249005. [DOI] [PubMed] [Google Scholar]
  120. Spitznas M. Pathogenesis of central serous retinopathy: a new working hypothesis. Graefes Arch Clin Exp Ophthalmol. 1986;224(4):321–324. doi: 10.1007/BF02150023. [DOI] [PubMed] [Google Scholar]
  121. Straatsma B. R., Allen R. A., Pettit T. H. Central serous retinopathy. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1966;47:107–127. [PubMed] [Google Scholar]
  122. Theodossiadis G., Tongos D. Treatment of central serous retinopathy. A comparative study with and without light coagulation. Ophthalmologica. 1974;169(6):416–431. doi: 10.1159/000307146. [DOI] [PubMed] [Google Scholar]
  123. Thoresen C. E., Telch M. J., Eagleston J. R. Approaches to altering the type A behavior pattern. Psychosomatics. 1981 Jun;22(6):472–482. doi: 10.1016/S0033-3182(81)73495-9. [DOI] [PubMed] [Google Scholar]
  124. Tolentino F. I., Freeman H. M., Schepens C. L. Vitreoretinal traction in serous and hemorrhagic macular retinopathy. A biomicroscopic study. Arch Ophthalmol. 1967 Jul;78(1):23–30. doi: 10.1001/archopht.1967.00980030025005. [DOI] [PubMed] [Google Scholar]
  125. Uyama M., Okuma M. [Photocoagulation of central serous retinopathy]. Nihon Ganka Kiyo. 1970 Jun;21(6):454–474. [PubMed] [Google Scholar]
  126. VON EULERU QUANTITATION OF STRESS BY CATECHOLAMINE ANALYSIS. Clin Pharmacol Ther. 1964 Jul-Aug;5:398–404. doi: 10.1002/cpt196454398. [DOI] [PubMed] [Google Scholar]
  127. Vaillant G. E. Natural history of male psychologic health: effects of mental health on physical health. N Engl J Med. 1979 Dec 6;301(23):1249–1254. doi: 10.1056/NEJM197912063012302. [DOI] [PubMed] [Google Scholar]
  128. Van Egeren L. F. Social interactions, communications, and the coronary-prone behavior pattern: a psychophysiological study. Psychosom Med. 1979 Feb;41(1):2–18. doi: 10.1097/00006842-197902000-00002. [DOI] [PubMed] [Google Scholar]
  129. WAGENER H. P. Central angiospastic retinopathy and central serous chorioretinitis. Am J Med Sci. 1957 Feb;233(2):220–232. doi: 10.1097/00000441-195702000-00014. [DOI] [PubMed] [Google Scholar]
  130. WOLKOWICZ M. I. Central serous retinopathy; clinical and experimental studies. Am J Ophthalmol. 1956 Oct;42(4 Pt 1):531–545. [PubMed] [Google Scholar]
  131. Wardwell W. I., Bahnson C. B. Behavioral variables and myocardial infarction in the southeastern Connecticut heart study. J Chronic Dis. 1973 Jul;26(7):447–461. doi: 10.1016/0021-9681(73)90096-9. [DOI] [PubMed] [Google Scholar]
  132. Weiter J. J., Schachar R. A., Ernest J. T. Control of intraocular blood flow. II. Effects of sympathetic tone. Invest Ophthalmol. 1973 May;12(5):332–334. [PubMed] [Google Scholar]
  133. Williams R. B., Jr, Haney T. L., Lee K. L., Kong Y. H., Blumenthal J. A., Whalen R. E. Type A behavior, hostility, and coronary atherosclerosis. Psychosom Med. 1980 Nov;42(6):539–549. doi: 10.1097/00006842-198011000-00002. [DOI] [PubMed] [Google Scholar]
  134. Williams R. B., Jr, Lane J. D., Kuhn C. M., Melosh W., White A. D., Schanberg S. M. Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science. 1982 Oct 29;218(4571):483–485. doi: 10.1126/science.7123248. [DOI] [PubMed] [Google Scholar]
  135. Williamson J., Nuki G. Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol. 1970 Jun;54(6):405–409. doi: 10.1136/bjo.54.6.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Wise G. N., Campbell C. J., Wendler P. F., Rittler M. C. Photocoagulation of vascular lesions of the macula. Am J Ophthalmol. 1968 Sep;66(3):452–459. doi: 10.1016/0002-9394(68)91531-6. [DOI] [PubMed] [Google Scholar]
  137. Yannuzzi L. A., Shakin J. L., Fisher Y. L., Altomonte M. A. Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. Ophthalmology. 1984 Dec;91(12):1554–1572. doi: 10.1016/s0161-6420(84)34117-3. [DOI] [PubMed] [Google Scholar]
  138. Yasuzumi T., Miki T., Sugimoto K. [Electronmicroscopic studies of epinephrine choroiditis in rabbits. I. Pigment epithelium and Bruch's membrane in the healed stage (author's transl)]. Nippon Ganka Gakkai Zasshi. 1974 Aug;78(8):588–598. [PubMed] [Google Scholar]
  139. Yoshioka H., Katsume Y., Akune H. Experimental central serous chorioretinopathy in monkey eyes: fluorescein angiographic findings. Ophthalmologica. 1982;185(3):168–178. doi: 10.1159/000309239. [DOI] [PubMed] [Google Scholar]
  140. Yoshioka H., Katsume Y. Experimental central serous chorioretinopathy. III: ultrastructural findings. Jpn J Ophthalmol. 1982;26(4):397–409. [PubMed] [Google Scholar]
  141. Yoshioka H., Sugita T., Nagayoshi K. [Fluorescein angiographic findings in experimental retinopathy produced by intravenous adrenaline injection. Preliminary report]. Nihon Ganka Kiyo. 1970 Sep;21(9):648–652. [PubMed] [Google Scholar]
  142. Zumoff B., Rosenfeld R. S., Friedman M., Byers S. O., Rosenman R. H., Hellman L. Elevated daytime urinary excretion of testosterone glucuronide in men with the type A behavior pattern. Psychosom Med. 1984 May-Jun;46(3):223–225. doi: 10.1097/00006842-198405000-00004. [DOI] [PubMed] [Google Scholar]
  143. Zyzanski S. J., Jenkins C. D., Ryan T. J., Flessas A., Everist M. Psychological correlates of coronary angiographic findings. Arch Intern Med. 1976 Nov;136(11):1234–1237. [PubMed] [Google Scholar]
  144. von Eiff A. W., Friedrich G., Neus H., Rüddel H., Schmieder R. Effects of beta-blockers on type-A coronary-prone behaviour. Klin Wochenschr. 1982 Oct 15;60(20):1315–1316. doi: 10.1007/BF01727489. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES